LB Pharmaceuticals Inc (LBRX)Healthcare | Biotechnology | New York, United States | NasdaqGM
32.66 USD
+0.99
(3.126%)
⇧
(April 21, 2026, 12:05 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:52 p.m. EDT
LBX exhibits classic biotech volatility with strong but risky momentum; short-term trading leans bearish due to recent rally exhaustion, while long-term holds promise but suffers from negative fundamentals. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.036849 |
| MSTL | 0.087848 |
| AutoETS | 0.088608 |
| AutoARIMA | 0.088724 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 71% |
| H-stat | 1.41 |
| Ljung-Box p | 0.007 |
| Jarque-Bera p | 0.894 |
| Excess Kurtosis | 0.31 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.184 |
| Market Cap | 936,517,056 |
| Forward P/E | -7.65 |
| Website | https://lbpharma.us |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.8306358 |
| Address1 | One Pennsylvania Plaza |
| Address2 | Suite 1025 |
| All Time High | 32.49 |
| All Time Low | 13.36 |
| Ask | 40.92 |
| Ask Size | 2 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 388,990 |
| Average Daily Volume3 Month | 253,937 |
| Average Volume | 253,937 |
| Average Volume10Days | 388,990 |
| Bid | 23.62 |
| Bid Size | 2 |
| Book Value | 11.91 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 32.6599 |
| Current Ratio | 41.445 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 32.905 |
| Day Low | 31.6 |
| Debt To Equity | 1.184 |
| Display Name | LB Pharmaceuticals |
| Earnings Timestamp End | 1,778,875,200 |
| Earnings Timestamp Start | 1,778,875,200 |
| Ebitda | -29,183,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -21.125 |
| Enterprise Value | 616,487,744 |
| Eps Current Year | -3.705 |
| Eps Forward | -4.27 |
| Eps Trailing Twelve Months | -3.13 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 24.9134 |
| Fifty Day Average Change | 7.7465 |
| Fifty Day Average Change Percent | 0.31093708 |
| Fifty Two Week Change Percent | 83.063576 |
| Fifty Two Week High | 32.905 |
| Fifty Two Week High Change | -0.24509811 |
| Fifty Two Week High Change Percent | -0.007448659 |
| Fifty Two Week Low | 13.36 |
| Fifty Two Week Low Change | 19.2999 |
| Fifty Two Week Low Change Percent | 1.4446033 |
| Fifty Two Week Range | 13.36 - 32.905 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,757,597,400,000 |
| Float Shares | 19,712,223 |
| Forward Eps | -4.27 |
| Forward P E | -7.648689 |
| Free Cashflow | -27,229,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0027 |
| Held Percent Institutions | 0.96499 |
| Implied Shares Outstanding | 28,674,827 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-09-11 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York. |
| Long Name | LB Pharmaceuticals Inc |
| Market | us_market |
| Market Cap | 936,517,056 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_413161432 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -25,205,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 908,131,771 |
| Number Of Analyst Opinions | 5 |
| Open | 31.7 |
| Operating Cashflow | -35,208,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 212 605 0300 |
| Previous Close | 31.67 |
| Price Eps Current Year | -8.815088 |
| Price Hint | 2 |
| Price To Book | 2.7422252 |
| Profit Margins | 0.0 |
| Quick Ratio | 39.669 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | 0.9899006 |
| Regular Market Change Percent | 3.1256728 |
| Regular Market Day High | 32.905 |
| Regular Market Day Low | 31.6 |
| Regular Market Day Range | 31.6 - 32.905 |
| Regular Market Open | 31.7 |
| Regular Market Previous Close | 31.67 |
| Regular Market Price | 32.6599 |
| Regular Market Time | 1,776,787,506 |
| Regular Market Volume | 123,955 |
| Return On Assets | -0.10645001 |
| Return On Equity | -0.15703 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 28,674,827 |
| Shares Percent Shares Out | 0.091400005 |
| Shares Short | 2,621,739 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,615,602 |
| Short Name | LB Pharmaceuticals Inc |
| Short Percent Of Float | 0.0963 |
| Short Ratio | 10.43 |
| Source Interval | 15 |
| State | NY |
| Symbol | LBRX |
| Target High Price | 78.0 |
| Target Low Price | 31.0 |
| Target Mean Price | 43.8 |
| Target Median Price | 36.0 |
| Total Cash | 295,212,992 |
| Total Cash Per Share | 10.295 |
| Total Debt | 3,569,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.13 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 20.381842 |
| Two Hundred Day Average Change | 12.278059 |
| Two Hundred Day Average Change Percent | 0.60240185 |
| Type Disp | Equity |
| Volume | 123,955 |
| Website | https://lbpharma.us |
| Zip | 10,119 |